|
Originally published In Press as doi:10.1074/jbc.M203912200 on July 11, 2002
J. Biol. Chem., Vol. 277, Issue 37, 34117-34124, September 13, 2002
Leptin Promotes Biliary Cholesterol Elimination during Weight
Loss in ob/ob Mice by Regulating the
Enterohepatic Circulation of Bile Salts*
Hideyuki
Hyogo §,
Suheeta
Roy ,
Beverly
Paigen¶, and
David E.
Cohen **
From the Departments of Medicine and
Biochemistry, Marion Bessin Liver Research Center, Albert
Einstein College of Medicine, Bronx, New York 10461 and ¶ The
Jackson Laboratory, Bar Harbor, Maine 04609
Leptin administration to obese C57BL/6J
(ob/ob) mice results in weight loss by reducing body fat.
Because adipose tissue is an important storage depot for cholesterol,
we explored evidence that leptin-induced weight loss in
ob/ob mice was accompanied by transport of cholesterol to
the liver and its elimination via bile. Consistent with mobilization of
stored cholesterol, cholesterol concentrations in adipose tissue
remained unchanged during weight loss. Plasma cholesterol levels fell
sharply, and microscopic analyses of gallbladder bile revealed
cholesterol crystals as well as cholesterol gallstones. Surprisingly,
leptin reduced biliary cholesterol secretion rates without affecting
secretion rates of bile salts or phospholipids. Instead, cholesterol
supersaturation of gallbladder bile was due to marked decreases in bile
salt hydrophobicity and not to hypersecretion of biliary cholesterol
per se, such as occurs in humans during weight loss. In
addition to regulating bile salt composition, leptin treatment
decreased bile salt pool size. The smaller, more hydrophilic bile salt
pool was associated with substantial decreases in intestinal
cholesterol absorption. Within the liver, leptin treatment reduced the
activity of 3-hydroxy-3-methylglutaryl-CoA reductase, but it did not
change activities of cholesterol 7 -hydroxylase or
acyl-CoA:cholesterol acyltransferase. These data suggest that leptin
regulates biliary lipid metabolism to promote efficient elimination of
excess cholesterol stored in adipose tissue. Cholesterol gallstone
formation during weight loss in ob/ob mice appears to represent a pathologic consequence of an adaptive response that prevents absorption of biliary and dietary cholesterol.
*
This work was supported by National Institutes of Health
Grants DK48873 (to D. E. C.) and DK51568 (to B. P.) and
Grant DK 20514 from the Albert Einstein College of Medicine Diabetes
Research & Training Center.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipient of a grant from the Japan-North America Medical Exchange
Foundation and a Dr. Charles Trey Memorial American Liver Foundation
Postdoctoral Fellowship.
**
To whom correspondence should be addressed: Liver Research Center,
Ullmann 625, Albert Einstein College of Medicine, 1300 Morris Park
Ave., Bronx, NY 10461. Tel.: 718-430-2098; Fax: 718-430-8975; E-mail: dcohen@aecom.yu.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. F. Scapa, A. Pocai, M. K. Wu, R. Gutierrez-Juarez, L. Glenz, K. Kanno, H. Li, S. Biddinger, L. A. Jelicks, L. Rossetti, et al.
Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2
FASEB J,
July 1, 2008;
22(7):
2579 - 2590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Wooton-Kee, D. E. Cohen, and M. Vore
Increased cholesterol 7{alpha}-hydroxylase expression and size of the bile acid pool in the lactating rat
Am J Physiol Gastrointest Liver Physiol,
April 1, 2008;
294(4):
G1009 - G1016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Lloyd, J. McCormick, J. Helmering, K. W. Kim, M. Wang, P. Fordstrom, S. A. Kaufman, R. A. Lindberg, and M. M. Veniant
Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr
Am J Physiol Endocrinol Metab,
March 1, 2008;
294(3):
E496 - E505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Sabeva, E. J. Rouse, and G. A. Graf
Defects in the Leptin Axis Reduce Abundance of the ABCG5-ABCG8 Sterol Transporter in Liver
J. Biol. Chem.,
August 3, 2007;
282(31):
22397 - 22405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-J. Wang, J. M. Baez, R. Maurer, H. M. Dansky, and D. E. Cohen
Homozygous disruption of Pctp modulates atherosclerosis in apolipoprotein E-deficient mice
J. Lipid Res.,
November 1, 2006;
47(11):
2400 - 2407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Huang, N. Dedousis, A. Bandi, G. D. Lopaschuk, and R. M. O'Doherty
Liver Triglyceride Secretion and Lipid Oxidative Metabolism Are Rapidly Altered by Leptin in Vivo
Endocrinology,
March 1, 2006;
147(3):
1480 - 1487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Wu and D. E. Cohen
Phosphatidylcholine transfer protein regulates size and hepatic uptake of high-density lipoproteins
Am J Physiol Gastrointest Liver Physiol,
December 1, 2005;
289(6):
G1067 - G1074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Wu and D. E. Cohen
Altered hepatic cholesterol metabolism compensates for disruption of phosphatidylcholine transfer protein in mice
Am J Physiol Gastrointest Liver Physiol,
September 1, 2005;
289(3):
G456 - G461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Wu, H. Hyogo, S. K. Yadav, P. M. Novikoff, and D. E. Cohen
Impaired response of biliary lipid secretion to a lithogenic diet in phosphatidylcholine transfer protein-deficient mice
J. Lipid Res.,
March 1, 2005;
46(3):
422 - 431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Lundasen, W. Liao, B. Angelin, and M. Rudling
Leptin Induces the Hepatic High Density Lipoprotein Receptor Scavenger Receptor B Type I (SR-BI) but Not Cholesterol 7{alpha}-Hydroxylase (Cyp7a1) in Leptin-deficient (ob/ob) Mice
J. Biol. Chem.,
October 31, 2003;
278(44):
43224 - 43228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Guilmeau, M. Buyse, A. Tsocas, J. P. Laigneau, and A. Bado
Duodenal Leptin Stimulates Cholecystokinin Secretion: Evidence of a Positive Leptin-Cholecystokinin Feedback Loop
Diabetes,
July 1, 2003;
52(7):
1664 - 1672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hyogo, S. Roy, and D. E. Cohen
Restoration of gallstone susceptibility by leptin in C57BL/6J ob/ob mice
J. Lipid Res.,
June 1, 2003;
44(6):
1232 - 1240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Erickson, S. R. Lear, S. Deane, S. Dubrac, S. L. Huling, L. Nguyen, J. S. Bollineni, S. Shefer, H. Hyogo, D. E. Cohen, et al.
Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice
J. Lipid Res.,
May 1, 2003;
44(5):
1001 - 1009.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|